IntelliPharmaCeutics International (TSXV:IPCI) FCF Yield % : 6.20 (As of May. 01, 2024)

View and export this data going back to 1999. Start your Free Trial

What is IntelliPharmaCeutics International FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, IntelliPharmaCeutics International's Trailing 12-Month Free Cash Flow is C$0.16 Mil, and Market Cap is C$2.65 Mil. Therefore, IntelliPharmaCeutics International's FCF Yield % for today is 6.20%.

The historical rank and industry rank for IntelliPharmaCeutics International's FCF Yield % or its related term are showing as below:

TSXV:IPCI' s FCF Yield % Range Over the Past 10 Years
Min: -804.94 Med: -15.4 Max: 19.56
Current: 6.2

During the past 13 years, the highest FCF Yield % of IntelliPharmaCeutics International was 19.56%. The lowest was -804.94%. And the median was -15.40%.

TSXV:IPCI's FCF Yield % is ranked better than
96.39% of 1551 companies
in the Biotechnology industry
Industry Median: -15.06 vs TSXV:IPCI: 6.20

IntelliPharmaCeutics International's FCF Margin % for the quarter that ended in Aug. 2023 was 349.46%.

IntelliPharmaCeutics International FCF Yield % Historical Data

The historical data trend for IntelliPharmaCeutics International's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntelliPharmaCeutics International FCF Yield % Chart

IntelliPharmaCeutics International Annual Data

Trend

Nov13

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

FCF Yield %

Get a 7-Day Free Trial

-202.73

-200.13

3.72

-64.46

-56.45

IntelliPharmaCeutics International Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
FCF Yield %	Get a 7-Day Free Trial															-39.73	-31.91	-3.06	19.66	41.35

Competitive Comparison of IntelliPharmaCeutics International's FCF Yield %

For the Biotechnology subindustry, IntelliPharmaCeutics International's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IntelliPharmaCeutics International's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IntelliPharmaCeutics International's FCF Yield % distribution charts can be found below:

* The bar in red indicates where IntelliPharmaCeutics International's FCF Yield % falls into.

IntelliPharmaCeutics International FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

IntelliPharmaCeutics International's FCF Yield % for the fiscal year that ended in Nov. 2022 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-1.868	/	3.30927
	=	-56.45%

IntelliPharmaCeutics International's annualized FCF Yield % for the quarter that ended in Aug. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0.325	*	4	/	3.1438065
	=	41.35%

IntelliPharmaCeutics International FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

IntelliPharmaCeutics International FCF Yield % Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

IntelliPharmaCeutics International (TSXV:IPCI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IntelliPharmaCeutics International Inc (TSXV:IPCI) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

IPCIF:USA I4AA:Germany

Address

30 Worcester Road, Toronto, ON, CAN, M9W 5X2

Website

https://www.intellipharmaceutics.com

IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.

IntelliPharmaCeutics International (TSXV:IPCI) Headlines

No Headlines